These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 39267173)

  • 1. Identification of macrophage driver genes in fibrosis caused by different heart diseases based on omics integration.
    Zhang YZ; Wu Y; Li MJ; Mijiti A; Cheng LF
    J Transl Med; 2024 Sep; 22(1):839. PubMed ID: 39267173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-cell insights: pioneering an integrated atlas of chromatin accessibility and transcriptomic landscapes in diabetic cardiomyopathy.
    Su Q; Huang W; Huang Y; Dai R; Chang C; Li QY; Liu H; Li Z; Zhao Y; Wu Q; Pan DG
    Cardiovasc Diabetol; 2024 Apr; 23(1):139. PubMed ID: 38664790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regenerative cross talk between cardiac cells and macrophages.
    Whitehead AJ; Engler AJ
    Am J Physiol Heart Circ Physiol; 2021 Jun; 320(6):H2211-H2221. PubMed ID: 33769920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional networks of nucleocytoplasmic transport-related genes differentiate ischemic and dilated cardiomyopathies. A new therapeutic opportunity.
    Molina-Navarro MM; Triviño JC; Martínez-Dolz L; Lago F; González-Juanatey JR; Portolés M; Rivera M
    PLoS One; 2014; 9(8):e104709. PubMed ID: 25137373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21-Dependent Macrophage-to-Fibroblast Signaling Determines the Cardiac Response to Pressure Overload.
    Ramanujam D; Schön AP; Beck C; Vaccarello P; Felician G; Dueck A; Esfandyari D; Meister G; Meitinger T; Schulz C; Engelhardt S
    Circulation; 2021 Apr; 143(15):1513-1525. PubMed ID: 33550817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator inhibitor-1 reduces cardiac fibrosis and promotes M2 macrophage polarization in inflammatory cardiomyopathy.
    Baumeier C; Escher F; Aleshcheva G; Pietsch H; Schultheiss HP
    Basic Res Cardiol; 2021 Jan; 116(1):1. PubMed ID: 33432417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prioritizing Candidates of Post-Myocardial Infarction Heart Failure Using Plasma Proteomics and Single-Cell Transcriptomics.
    Chan MY; Efthymios M; Tan SH; Pickering JW; Troughton R; Pemberton C; Ho HH; Prabath JF; Drum CL; Ling LH; Soo WM; Chai SC; Fong A; Oon YY; Loh JP; Lee CH; Foo RSY; Ackers-Johnson MA; Pilbrow A; Richards AM
    Circulation; 2020 Oct; 142(15):1408-1421. PubMed ID: 32885678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated analysis of single-cell RNA sequencing and bulk RNA data reveals gene regulatory networks and targets in dilated cardiomyopathy.
    Zhang M; Zhang X; Niu J; Hua C; Liu P; Zhong G
    Sci Rep; 2024 Jun; 14(1):13942. PubMed ID: 38886541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tenascin-C accelerates adverse ventricular remodelling after myocardial infarction by modulating macrophage polarization.
    Kimura T; Tajiri K; Sato A; Sakai S; Wang Z; Yoshida T; Uede T; Hiroe M; Aonuma K; Ieda M; Imanaka-Yoshida K
    Cardiovasc Res; 2019 Mar; 115(3):614-624. PubMed ID: 30295707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of galectin-3 post-infarction impedes progressive fibrosis by regulating inflammatory profibrotic cascades.
    Wang X; Gaur M; Mounzih K; Rodriguez HJ; Qiu H; Chen M; Yan L; Cooper BA; Narayan S; Derakhshandeh R; Rao P; Han DD; Nabavizadeh P; Springer ML; John CM
    Cardiovasc Res; 2023 Nov; 119(15):2536-2549. PubMed ID: 37602717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-Specific Pathways Supporting Persistent Fibrosis in Heart Failure.
    Farris SD; Don C; Helterline D; Costa C; Plummer T; Steffes S; Mahr C; Mokadam NA; Stempien-Otero A
    J Am Coll Cardiol; 2017 Jul; 70(3):344-354. PubMed ID: 28705316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage and fibroblast trajectory inference and crosstalk analysis during myocardial infarction using integrated single-cell transcriptomic datasets.
    Ke D; Cao M; Ni J; Yuan Y; Deng J; Chen S; Dai X; Zhou H
    J Transl Med; 2024 Jun; 22(1):560. PubMed ID: 38867219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure.
    Sweet ME; Cocciolo A; Slavov D; Jones KL; Sweet JR; Graw SL; Reece TB; Ambardekar AV; Bristow MR; Mestroni L; Taylor MRG
    BMC Genomics; 2018 Nov; 19(1):812. PubMed ID: 30419824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac macrophages adopt profibrotic/M2 phenotype in infarcted hearts: Role of urokinase plasminogen activator.
    Carlson S; Helterline D; Asbe L; Dupras S; Minami E; Farris S; Stempien-Otero A
    J Mol Cell Cardiol; 2017 Jul; 108():42-49. PubMed ID: 27262672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of plasma TSG-6 with cardiac function, myocardial fibrosis, and prognosis in dilated cardiomyopathy patients with heart failure.
    Xu L; Zhang Y; Kuang Y; Fang H; Ma Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jul; 46(7):689-696. PubMed ID: 34382584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proto-oncogene tyrosine protein kinase Src is essential for macrophage-myofibroblast transition during renal scarring.
    Tang PM; Zhou S; Li CJ; Liao J; Xiao J; Wang QM; Lian GY; Li J; Huang XR; To KF; Ng CF; Chong CC; Ma RC; Lee TL; Lan HY
    Kidney Int; 2018 Jan; 93(1):173-187. PubMed ID: 29042082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL (Interleukin)-10-STAT3-Galectin-3 Axis Is Essential for Osteopontin-Producing Reparative Macrophage Polarization After Myocardial Infarction.
    Shirakawa K; Endo J; Kataoka M; Katsumata Y; Yoshida N; Yamamoto T; Isobe S; Moriyama H; Goto S; Kitakata H; Hiraide T; Fukuda K; Sano M
    Circulation; 2018 Oct; 138(18):2021-2035. PubMed ID: 29967195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing.
    Courties G; Heidt T; Sebas M; Iwamoto Y; Jeon D; Truelove J; Tricot B; Wojtkiewicz G; Dutta P; Sager HB; Borodovsky A; Novobrantseva T; Klebanov B; Fitzgerald K; Anderson DG; Libby P; Swirski FK; Weissleder R; Nahrendorf M
    J Am Coll Cardiol; 2014 Apr; 63(15):1556-66. PubMed ID: 24361318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Widespread Translational Control of Fibrosis in the Human Heart by RNA-Binding Proteins.
    Chothani S; Schäfer S; Adami E; Viswanathan S; Widjaja AA; Langley SR; Tan J; Wang M; Quaife NM; Jian Pua C; D'Agostino G; Guna Shekeran S; George BL; Lim S; Yiqun Cao E; van Heesch S; Witte F; Felkin LE; Christodoulou EG; Dong J; Blachut S; Patone G; Barton PJR; Hubner N; Cook SA; Rackham OJL
    Circulation; 2019 Sep; 140(11):937-951. PubMed ID: 31284728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing collapsin response mediator protein-2 reprograms macrophage phenotype and improves infarct healing in experimental myocardial infarction model.
    Zhou LS; Zhao GL; Liu Q; Jiang SC; Wang Y; Zhang DM
    J Inflamm (Lond); 2015; 12():11. PubMed ID: 25685072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.